HomeFilePharmacology

Pharmacology

View Category

Antithrombotic Anticoagulants

Cilostazol reduces restenosis of DES in lesions larger than 40 mm.

Original title: Comparison of Dual Versus Triple Antiplatelet Therapy After Drug-Eluting Stent According to Stent Length (from the...
solaci -
Learn More
Acute coronary syndromes

Ticagrelor effective in venous bridges

Original title: Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass grafo surgery: Inssights...
solaci -
Learn More
Antiplatelet

Enoxaparin appears superior to unfractionated heparin in patients undergoing primary angioplasty

Original title: A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the...
solaci -
Learn More
Acute coronary syndromes

Ticagrelor reduces in-stent thrombosis in patients with acute coronary syndromes

Original title: Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: An analysis from the...
solaci -
Learn More
Antiplatelet

Rivaroxaban reduces in-stent thrombosis in patients with acute coronary syndromes

Original title: Reduction of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Rivaroxaban in ATLAS-ACS 2...
solaci -
Learn More
Antiplatelet

Transradial access plus bivalirudin, the best combination to reduce bleeding

Original title: Comparison of bivalirudin and radial access across a spectrum of preprocedural risk of bleeding in percutaneous...
solaci -
Learn More
Interventional Cardiologists

Riociguat, a new drug for pulmonary arterial hypertension

Título original: Riociguat for the Treatment of Pulmonary Arterial Hypertension. Referencia: Hossein-Ardeschir Ghofrani et al. N Engl J Med 2013;369:330-40.  Many...
solaci -
Learn More
Acute coronary syndromes

Ticagrelor similar to clopidogrel in terms of coronary flow and myocardial perfusion

Título original: Angiographic Outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes). Referencia: Vijay Kunadian et al. J Am...
solaci -
Learn More